Travere Therapeutics to Participate at Upcoming Investor Conferences
SAN DIEGO–(BUSINESS WIRE)–
Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will participate in the following upcoming investor conferences:
BofA Securities 2026 Health Care Conference
Presenting on Wednesday, May 13, 2026, at 5:20 p.m. ET (2:20 p.m. PT)
2026 Jefferies Global Healthcare Conference
Presenting on Wednesday, June 3, 2026, at 8:45 a.m. ET
Goldman Sachs 47th Annual Global Healthcare Conference 2026
Presenting on Monday, June 8, 2026, at 11:20 a.m. ET
Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-and-presentations. Replays will be available for up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260507216351/en/
Investors:
888-969-7879
[email protected]
Media:
888-969-7879
[email protected]
KEYWORDS: California United States North America
INDUSTRY KEYWORDS: Biotechnology Health Science Pharmaceutical Research
MEDIA:
| Logo |
 |